EyePoint Pharmaceuticals, Inc., a pharmaceutical company committed to developing and commercializing therapeutics to help improve the lives of patients with serious eye disorders, announced financial results for the second quarter ended June 30, 2021 and highlighted recent corporate developments.
August 4, 2021
· 12 min read